Factors associated with physician assessment of severity of asthma or COPD in NOVELTY
A. Papi (Ferrara, Italy), H. Reddel (Sydney, Australia), A. Agustí (Barcelona, Spain), G. Anderson (Victoria, Australia), A. Bansal (Cambridge, United Kingdom), R. Beasley (Wellington, New Zealand), E. Bel (Amsterdam, Netherlands), C. Janson (Uppsala, Sweden), B. Make (Denver, CO, United States of America), I. Pavord (Oxford, United Kingdom), D. Price (Aberdeen, United Kingdom), E. Rapsomaniki (Cambridge, United Kingdom), D. Finch (Cambridge, United Kingdom), M. Alacqua (Cambridge, United Kingdom), H. Müllerová (Cambridge, United Kingdom), R. Hughes (Cambridge, United Kingdom)
Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases
Session: New tools for diagnosis of obstructive diseases
Session type: E-poster session
Number: 2201
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Papi (Ferrara, Italy), H. Reddel (Sydney, Australia), A. Agustí (Barcelona, Spain), G. Anderson (Victoria, Australia), A. Bansal (Cambridge, United Kingdom), R. Beasley (Wellington, New Zealand), E. Bel (Amsterdam, Netherlands), C. Janson (Uppsala, Sweden), B. Make (Denver, CO, United States of America), I. Pavord (Oxford, United Kingdom), D. Price (Aberdeen, United Kingdom), E. Rapsomaniki (Cambridge, United Kingdom), D. Finch (Cambridge, United Kingdom), M. Alacqua (Cambridge, United Kingdom), H. Müllerová (Cambridge, United Kingdom), R. Hughes (Cambridge, United Kingdom). Factors associated with physician assessment of severity of asthma or COPD in NOVELTY. 2201
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: